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httpcense.Abstract Background: Skeletal muscle dysfunction is one of the important systemic manifesta-
tions of chronic obstructive pulmonary disease (COPD) and is associated with mortality in those
patients thus quantifying its bulk and strength is of great clinical interest and of particular value.
Objective: Evaluation of quadriceps muscle bulk & strength in patients with moderate to severe
stable COPD compared with normal healthy subjects and the effect of progressive resistant exercise
program for 12 weeks on quadriceps muscle strength and exercise capacity.
Subjects and methods: Forty patients with moderate to severe stable COPD they were 26 males
and 14 females. Ten healthy subjects with the same age and sex were also included as controls. All
patients and controls were evaluated at baseline for quadriceps maximal voluntary contraction
(QMVC), exercise capacity, the mid – thigh cross sectional area (MTCSA) and spirometric pulmon-
ary functions then patients were classiﬁed into 2 groups only group one performed the progressive
resistant exercise program for 12 weeks then reassessment of both group were done.
Results: Patients and controls were matched as regard age, weight, height and body mass index.
There was signiﬁcant difference between patients and control in QMVC, MTCSA, and FFM after
training for 12 weeks only group one had signiﬁcant difference in QMVC, MTCSA and FFM/Kg in
comparison to the baseline, while there was no signiﬁcant difference as regard the pulmonary
functions. Also there was signiﬁcant difference between group 1 and 2 after 12 weeks in QQMVC,
MTCSA and FFM/kg.(H. Shaarawy).
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80 N. Affara et al.Conclusion: We have collected evidence indicating that both bulk and strength of quadriceps
muscles in particular were reduced in patients with COPD compared with normal controls and
these changes can be improved with progressive training without change in pulmonary functions.
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Chronic obstructive pulmonary disease (COPD) is a major
medical problem and a leading cause of morbidity and mortal-
ity among the adult population worldwide. It is a debilitating
disease characterized by inﬂammation-induced airﬂow limita-
tion and parenchymal destruction [1]. In addition to pulmonary
manifestations, patients with COPD develop systemic problems
including skeletal muscle and other organ-speciﬁc dysfunctions.
Peripheral skeletal muscle dysfunction has been recognized as
one of the most important systemic manifestations of COPD
[2]. Recent evidence indicates that acute exacerbations of
COPD aggravate the extra-pulmonary consequences of the dis-
ease; on the other hand avoidance of physical activities is likely
to increases the risk of new exacerbations [3]. Patients with
COPD may exhibit cachexia or skeletal muscle dysfunction
[4]. Quadriceps muscle weakness is an important complication
of COPD and reduced quadriceps bulk and strength are associ-
ated with impaired exercise capacity and greater mortality [5].
Its etiology is multifactorial and evidence is growing that it is
partly determined by genetic susceptibility [6]. Many patients
with COPD suffer from exercise intolerance and in about
40% of the patients exercise capacity is limited by alterations
in skeletal muscle rather than pulmonary problems [7]. Ventila-
tory impairment was thought to be the major limiter of exercise
capacity in these patients because exercise impairment usually
correlated with the loss of ventilatory capacity. Over the last 2
decades, however, it has become increasingly apparent that
exercise intolerance in patients with COPD is often multifacto-
rial and can involve various combinations of ventilatory impair-
ment, gas-exchange abnormalities, cardiovascular and skeletal
muscle dysfunctions [8].
Objective
Evaluation of quadriceps muscle bulk & strength in patients
with moderate to severe stable COPD compared with normal
healthy subjects and the effect of progressive resistant exercise
program for 12 weeks on quadriceps muscle strength and exer-
cise capacity.
Subjects and methods
The present study was done in AlRashed center for allergy and
respiratory diseases and pulmonary rehabilitation center, Min-
istry of health, state of Kuwait over the period between Janu-
ary 2011 and February 2012. Forty patients with moderate to
severe stable COPD were studied. They were 26 males and 14
females, they were recruited and followed up in outpatient and
diagnosed according to GOLD criteria [9]. Ten healthy sub-
jects with the same age, sex were also included as controls.
All patients and controls were evaluated at baseline for quad-
riceps maximal voluntary contraction (QMVC), exercisecapacity, the mid – thigh cross sectional area (MTCSA) and
spirometric pulmonary functions using Care Fusion master
screen MS. IOS 733-765 (FEV1, FVC, FEV1/FVC) then pa-
tients were classiﬁed into 2 groups:
Group 1
Twenty-eight patients undergone training protocol for lower
limb muscles especially quadriceps muscles for 30 min and
neuromuscular electrical stimulation (ES) of both quadriceps
for 15 min three times weekly for 12 weeks and reassessed after
12 weeks.
Group 2
Twelve patients not trained and reassessed after 12 weeks
Exclusion criteria
Participants with co morbidities such as cardiovascular dis-
ease, primary pulmonary hypertension and neurologic or
orthopedic problems limiting exercise were excluded. Patients
considered clinically unstable (who presented with changes in
medication dose or frequency, disease exacerbation or hospital
admissions in the preceding 8 weeks) also were excluded.
All patients were subjected to
(1) History taking and physical examination.
(2) Body weight and height were measured and body mass
index (BMI = weight/height2) was calculated [10].
(3) Body composition evaluated using InBody 3.0 body com-
position analyzer (100-120/200-240 V-50/60 Hz, 40 VA).
Fat – free mass (FFM / kg) was calculated, The FFM
index (FFMI = FFM/height2) was also calculated. Lean
body mass depletion was deﬁned as an FFMI<15 kg/m2
for women and <16 kg/m2 for men [11].
(4) Quadriceps muscle strength.
Assessed in both patients and controls by recording the iso-
metric quadriceps maximal voluntary contraction (QMVC) in
kg = (The highest mean force that could be sustained over one
second). The dominant leg was used for testing using an elec-
tronic hand – held dynamometry (HHD) (Lafayette Manual
Muscle Test System, Model 01163; Lafayette Instrument
Co., Lafayette, IN). All subjects were studied keeping the knee
ﬂexed at 90˚over the end of the chair. A padded strap was con-
nected to the dynamometer then ﬁxed to the ankle proximal to
medial malleolus. Subjects were asked to extend their knee
maximally against the dynamometer around the ankle consec-
utive efforts were made at 30 s intervals with verbal encourage-
ment until no further increase in QMVC occurred. Hand-held
dynamometry is a portable and inexpensive method to quan-
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changed [12].
(1) Functional capacity measured using the 6 – minute
walking test (6MWT), this test is better tolerated and
more reﬂective of activity of daily living (ADL) and
exercise capacity .The distance that a patients can
quickly walk as he can in a period of 6 min were mea-
sured [13].
(2) Pulmonary function testing: the forced expiratory vol-
ume in ﬁrst second (FEV1), the forced vital capacity
(FVC) and the FEV1/FVC ratio [14].
(3) Modiﬁed Borg scale (MBS) provides easy and rapid infor-
mation about a patient’s subjective state of dyspnea. The
patients were asked to rate their dyspnea by selecting the
number with the corresponding word he most appropri-
ately described their sensation of breathlessness [15].
(4) CT of the mid – thigh for patients and controls. A CT
scan of the right thigh halfway between the symphysis
pubis and the inferior condyle of the femur was per-
formed. The mid thigh muscle cross-sectional area
(MTCSA) was obtained.Training protocol
(1) The exercise program done for 30 min, three times
weekly, for 12 weeks and consists of active limb mobili-
zations (ALMs) for 10 min, which were performed with
the patient in lying down on a physiotherapist table.
Patients also performed slow walking exercise on a
treadmill for 5–10 min and an incremental bicycle exer-
cise were performed on a bicycle ergometer for 5–
10 min with periods of rest during exercises.
(2) Neuromuscular electro-stimulation (ES) was done to
both quadriceps for 15 min before starting exercise pro-
gram. The symmetrical, biphasic, square-pulsed current
were used and the equipment used was Sonopuls 492
(Enraf Nonius) the intensity applied was set as the max-
imal tolerable intensity by the patient and was increased
gradually each session.
(3) In addition to home program of both walking and
cycling to improve exercise performance.Statistical analysis
The Data was collected and tabulated. Statistical analysis was
done using Statistical Package for Social Sciences (SPSS/ver-
sion 17) software. Arthematic mean, standard deviation, num-
ber and percent, for categorized parameters were used, paired
T test was used to compare between categories of the same
group at base – line and after 12 weeks while unpaired T test
was used to compare data between both groups and between
patients and controls, spearman correlation was used to corre-
late between FEV1% pred. and QMVC, accepted signiﬁcance
was at the level of 0.05.
Results
There was no signiﬁcant difference between patients and con-
trols as regard the demographic criteria, the mean age of thepatients was 48 ± 10 years while the mean age of the controls
was 50 ± 9.2 (p> 0.05), the mean height of the patients was
168 ± 16 cm while the mean height of the controls was 166
± 18 cm (p> 0.05), the mean weight of the patients was 71
± 12.6 kg while the mean weight of the controls was 75 ±
8.1 kg (p> 0.05), the mean BMI of the patients was 26 ±
4 kg/m2 while the mean BMI of the controls was 25 ± 8 kg/
m2 (p> 0.05). The body composition of the patients showed
signiﬁcant difference from that of the controls: the FFM, total
fat/Kg, FFMI, and MTCSA were signiﬁcantly lower in the pa-
tients than in the controls (p< 0.05), As regard the physiologic
studies: QMVC was signiﬁcantly lower in the patients than in
the controls (p< 0.01), FEV1% pred., FVC% pred., FEV1/
FVC were all lower in the patients than in the controls
(p< 0.01). QMVC showed positive correlation with FEV1%
pred. (p< 0.01) Fig. 1 and Tables 1 and 2.
On comparison between group 1 and 2 at the base line there
was no signiﬁcant difference between both groups as regard
pulmonary function testing, dyspnea scale, 6 min walking dis-
tance, FFM (p> 0.05), Also there was no signiﬁcant differ-
ence between both groups as regard QMVC and CSA
(p> 0.05).
From the Table 3 there was no signiﬁcant difference in
FEV1% pred., 6 min walking distance, or dyspnea scale in
group 1 patients before and after training. QMVC was signiﬁ-
cantly increased after training for 12 weeks in group 1 patients
(p< 0.01), also FFM and CSA were increased signiﬁcantly
but to a lesser degree (p< 0.05). From the Tables 4 and 5 there
was no signiﬁcant change in group 2 patients in body composi-
tion or physiologic parameters after 12 weeks (p> 0.05). On
comparing both groups of patients after 12 weeks progressive
training improved the QMVC (p< 0.05), increased the FFM
and MTCSA (p< 0.05) while there was no signiﬁcant change
in FEV1% pred., 6 min walking distance or dyspnea scale
(p> 0.05).
Discussion
Patients with COPD often decrease their physical activity be-
cause exercise can worsen dyspnea and the progressive decondi-
tioning associated with inactivity initiates a vicious circle, with
dyspnea becoming problematic at ever lower physical demands.
Physical training program aims to break this cycle [16]. Our
study revealed signiﬁcant differences in the QMVC/kg
(37.1 ± 1.2) between patients and controls (53.2 ± 6.3) and
this reduction in QMVC of the patients was correlated posi-
tively with the pulmonary function (FEV1), these results were
in agreement with the study done by Chun-rong and Chen
[17], who investigated the prevalence and severity of skeletal
muscle dysfunction in stable COPD patients by measurement
of quadriceps strength with volitional and non-volitional tech-
niques in 71 patients and 60 controls. The QMVC was de-
creased by 44–47% in patients as compared with controls.
Kim H et al. [18] have conﬁrmed that the endurance of limb
muscles is attenuated by about 30% in patients with moderate
COPD and that poor muscle endurance in these patients corre-
lates positively with physical activity index and forced expira-
tory volume in one second (FEV1). Also, Swallow et al. [19],
reported alterations in muscle strength in COPD patients and
the degree of reduced limb muscle strength correlates with the
severity of the disease process. A study done by Seymour
et al. [4] showed that the overall prevalence of quadriceps weak-
Figure 1 Correlation between QMVC and FEV1% pred.
Table 1 Characteristics of patients and controls.
Characteristic Patients Controls
Age in years 48 ± 10 50 ± 9.2*
Height/cm 168 ± 16 166 ± 18*
Weight/kg 71 ± 12.6 75 ± 8.1*
BMI (kg/m2) 26 ± 4 25 ± 8*
FFM/kg 50.1 ± 12.5 57.6 ± 7.3**
Total fat/kg 19.5 ± 4.6 21.8 ± 5.3**
FFMI (kg/m2) 13.4 ± 4.8 17.3 ± 4.5 **
CSA/cm2 64.8 ± 2.6 68.9 ± 3.4**
QMVC/kg 37.1 ± 1.2 53.2 ± 6.3***
FEV1% pred. 55.6 ± 10.5 97.1 ± 10.2***
FEV1/FVC 67.2 ± 2.1 85.2 ± 2.3***
6-MWT 260.2 ± 56.1 398.2 ±62.5***
* Non signiﬁcant difference p> 0.05.
** Signiﬁcant difference p< 0.05.
*** Highly signiﬁcant difference p< 0.01.
Table 2 Comparison between two groups of patients at base –
line.
Characteristic Group (1) = 28 Group (2) = 12
FEV1% pred. 50.3 ± 5.4 48.6 ± 6.2*
FEV1/FVC 65.3 ± 3.2 66.2 ± 2.5*
6-MWT 263.5 ± 42.3 256.9 ± 51.2*
MBS 6.67 ± 2.1 7.51 ± 1.6*
QMVC/kg 36.2 ± 2.1 36.4 ± 1.9*
FFM/kg 47.2 ± 16.3 48.93 ± 14.4*
CSA/cm2 64.3 ± 2.5 65.3 ± 2.3*
* Non signiﬁcant difference p> 0.05.
Table 3 Differences in parameters of group 1 before & after
training program.
Characteristic At base – line After training
FEV1% 50.3 ± 5.4 51.2 ± 3.9*
6-MWT 263.5 ± 42.3 274.2 ± 33.5*
MBS 6.67 ± 2.1 6.68 ± 2.3*
QMVC/kg 36. 2 ± 2.1 41.3 ± 2.5***
FFM/kg 47.2 ± 14.3 49.1 ± 16.2**
CSA/cm 64.3 ± 2.5 68.1 ± 2.3**
* Non signiﬁcant difference p> 0.05
** Signiﬁcant difference p< 0.05
*** Highly signiﬁcant difference p< 0.01
Table 4 Parameters of group 2 at base – line and after 12
weeks.
At base – line After 12 weeks
FEV1% 48.6 ± 6.2 49.3 ± 5.6*
6-MWT 256.9 ± 51.2 259 ± 48.6*
MBS 7.51 ± 1.6 7.1 ± 1.9*
QMVC/kg 36.4 ± 1.9 36.5 ± 1.5*
FFM/kg 44.93 ± 16.4 44.1 ± 16.1*
CSA/cm 65.3 ± 1.8 63.7 ± 2.3*
* Non signiﬁcant difference p> 0.05.
Table 5 Comparison between both groups after 12 weeks.
Characteristic Group 1 Group 2
FEV1% 51.2 ± 3.9 49.3 ± 5.6*
6-MWT 274.2 ± 33.5 259 ± 48.6*
MBS 6.65 ± 2.3 7.1 ± 1.9*
QMVC/kg 41.3 ± 2.5 36.5 ± 1.5**
FFM/kg 49.1 ± 16.2 44.1 ± 16.1**
CSA/cm 68.1± 2.3 63.7 ± 2.3**
***Highly signiﬁcant difference p< 0.01.
* Non signiﬁcant difference p> 0.05.
** Signiﬁcant difference p< 0.05.
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Unsurprisingly the highest prevalence of weakness was ob-
served in those with the most severe airﬂow obstruction (38%
in GOLD stage 4); While a study done by Hopkinson N et al
[20], who studied 64 patients with stable COPD in two occa-
sions one year apart they reported that QMVC fell from
34.8(1.5) kg to 33.3(1.5) kg. The decline in quadriceps strength
was greatest in those with the highest strength at baseline and
not correlated with lung function, exacerbation frequency or
steroid treatment. Also, they found a decline in the fat free mass
(FFM) that was similarly higher in those with largest FFM atbaseline. In the present study after 12 weeks of training pro-
gram the quadriceps strength improved signiﬁcantly with
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fat-free (FFM) mass. Certainly, it has been observed in cohort
studies that up to a quarter to a third of COPD patients may
not improve their exercise capacity following pulmonary reha-
bilitation [21] and many clinical improvements and gains from
pulmonary rehabilitation decline towards baseline within
12 months. Furthermore, exercise training even in the labora-
tory setting does not appear to fully reverse all of the abnormal-
ities observed in the quadriceps muscle and some investigators
have used these observations to argue that inactivity may ex-
plain only part of the abnormalities observed in the peripheral
muscles [22]. Whereas others have argued that the duration of
general pulmonary rehabilitation program is inadequate or that
the considerable ventilatory limitations associated with COPD
impose constraints on the level of training [23]. Although there
does not appear to be a clear dose–response effect, some
authorities consider that longer pulmonary rehabilitation pro-
gram are associated with prolonged beneﬁts, although this is
not a universally held view [24]. However, Pitta et al. in 2008
[25] Suggested that a shorter program is sufﬁcient to induce a
measurable change in maximal exercise performance. A study
done by Gerovasili et al. In 2009 [26] have shown that electrical
muscle stimulation (EMS) may be an alternative to active exer-
cise in patients with (COPD). Forty-nine critically ill patients
(age: 59 ± 21 years) receive daily EMS sessions of both lower
extremities. Muscle mass was evaluated with ultrasound by
measuring the cross sectional diameter (CSD) of the vastus
intermedius and the rectus femoris of the quadriceps muscle.
They concluded that EMS is well tolerated and seems to pre-
serve the muscle mass of critically ill patients.
Conclusion
We have collected evidence indicating that both bulk and
strength of quadriceps muscles in particular were reduced in
patients with COPD compared with normal controls as de-
tected by reduced both QMVC & MTCSA and that these
abnormalities are improved after progressive resistant exercise
training for 12 weeks without change in pulmonary functions.References
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